JP6506763B2 - 家禽類における節足動物侵襲の処置または予防のためのイソオキサゾリン誘導体の使用 - Google Patents

家禽類における節足動物侵襲の処置または予防のためのイソオキサゾリン誘導体の使用 Download PDF

Info

Publication number
JP6506763B2
JP6506763B2 JP2016540559A JP2016540559A JP6506763B2 JP 6506763 B2 JP6506763 B2 JP 6506763B2 JP 2016540559 A JP2016540559 A JP 2016540559A JP 2016540559 A JP2016540559 A JP 2016540559A JP 6506763 B2 JP6506763 B2 JP 6506763B2
Authority
JP
Japan
Prior art keywords
isoxazoline compound
use according
methyl
formula
poultry
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016540559A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016540028A (ja
JP2016540028A5 (enExample
Inventor
ヘツカロス,アンニヤ・レギーナ
ゾラー,ハルトムート
フロシユレイ−シゴニヨー,アニー
ユイグ,ブリユノ
Original Assignee
インターベット インターナショナル ベー. フェー.
インターベット インターナショナル ベー. フェー.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by インターベット インターナショナル ベー. フェー., インターベット インターナショナル ベー. フェー. filed Critical インターベット インターナショナル ベー. フェー.
Publication of JP2016540028A publication Critical patent/JP2016540028A/ja
Publication of JP2016540028A5 publication Critical patent/JP2016540028A5/ja
Application granted granted Critical
Publication of JP6506763B2 publication Critical patent/JP6506763B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/80—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
JP2016540559A 2013-12-20 2014-12-19 家禽類における節足動物侵襲の処置または予防のためのイソオキサゾリン誘導体の使用 Active JP6506763B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13199007 2013-12-20
EP13199007.9 2013-12-20
PCT/EP2014/078636 WO2015091900A1 (en) 2013-12-20 2014-12-19 Use of isoxazoline derivatives for the treatment or prevention of arthropod infestations in poultry

Publications (3)

Publication Number Publication Date
JP2016540028A JP2016540028A (ja) 2016-12-22
JP2016540028A5 JP2016540028A5 (enExample) 2018-01-25
JP6506763B2 true JP6506763B2 (ja) 2019-04-24

Family

ID=49911279

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016540559A Active JP6506763B2 (ja) 2013-12-20 2014-12-19 家禽類における節足動物侵襲の処置または予防のためのイソオキサゾリン誘導体の使用

Country Status (12)

Country Link
US (4) US10272071B2 (enExample)
EP (2) EP3878281B1 (enExample)
JP (1) JP6506763B2 (enExample)
CN (2) CN110839641A (enExample)
BR (1) BR112016014216B1 (enExample)
ES (2) ES2874054T3 (enExample)
HU (2) HUE063842T2 (enExample)
MX (2) MX376210B (enExample)
PL (2) PL3878281T3 (enExample)
PT (1) PT3082806T (enExample)
RU (1) RU2688167C1 (enExample)
WO (1) WO2015091900A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2874054T3 (es) * 2013-12-20 2021-11-04 Intervet Int Bv Uso de derivados de isoxazolina para el tratamiento o la prevención de la infestación con artrópodos en aves de corral
MX373872B (es) * 2013-12-20 2020-03-26 Intervet Int Bv Composiciones de isoxazolina y uso de las mismas en la prevención o tratamiento de infestaciones parasitarias en animales.
BR112017027855B1 (pt) 2015-06-23 2022-11-16 Intervet International B.V. Composição farmacêutica, seu uso, água potável medicamentosa e método para sua preparação
WO2018039508A1 (en) * 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments
TWI834690B (zh) * 2018-07-18 2024-03-11 美商富曼西公司 用於防治無脊椎動物害蟲之異噁唑啉化合物
TW202012399A (zh) * 2018-09-12 2020-04-01 美商富曼西公司 用於防制無脊椎動物害蟲之異口咢唑啉化合物
WO2020201440A1 (en) * 2019-04-03 2020-10-08 Virbac Low dose fluralaner compositions for protection against parasitic invertebrate pest
WO2021122521A1 (en) * 2019-12-16 2021-06-24 Intervet International B.V. Composition for lice control in poultry
US12497370B2 (en) 2019-12-18 2025-12-16 Elanco Tiergesundheit Ag Isoxazoline derivatives
US12655138B2 (en) 2020-07-24 2026-06-16 Elanco Us Inc. Process for making an isoxazoline compound and intermediate thereof
AU2021335500A1 (en) 2020-09-04 2023-05-04 Elanco Us Inc. Palatable formulations
EP4430947A1 (en) 2023-03-17 2024-09-18 Przedsiebiorstwo Wielobranzowe "Vet-Agro" Sp. Z O.O. Therapeutic use of isoxazoline compounds, composition of isoxazoline compounds and kit for therapeutic use
US11903962B1 (en) * 2023-05-07 2024-02-20 Michael Farber Isoxazoline complexes and compositions thereof
PL449854A1 (pl) * 2024-09-18 2026-03-23 Okoniewski Piotr Kompozycja farmaceutyczna, lecznicza woda pitna, ich zastosowanie i sposób wytwarzania leczniczej wody pitnej

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0508140B1 (pt) 2004-03-05 2015-03-17 Nissan Chemical Ind Ltd Composto benzamida substituída por isoxazolina da fórmula (1); da fórmula (2) substituído por 3,5-bis (aril substituído); da fórmula (4) substituída por alquinibenzeno ou um sal do mesmo; "pesticida, agroquímico, inseticida, parasiticida contendo como ingrediente ativo um ou mais composto benzamida substituída por isoxazolina e sal do mesmo"
AU2006313007C1 (en) 2005-11-10 2019-10-03 Elanco Australasia Pty Limited Method of treating parasites
TW200803740A (en) 2005-12-16 2008-01-16 Du Pont 5-aryl isoxazolines for controlling invertebrate pests
TWI412322B (zh) 2005-12-30 2013-10-21 杜邦股份有限公司 控制無脊椎害蟲之異唑啉
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
DK2182945T3 (en) * 2007-06-27 2015-11-16 Du Pont PROCEDURE TO COMBAT PESTS WITH ANIMALS
TWI556741B (zh) * 2007-08-17 2016-11-11 英特威特國際股份有限公司 異唑啉組成物及其作為抗寄生蟲藥上的應用
TWI411395B (zh) 2007-12-24 2013-10-11 Syngenta Participations Ag 殺蟲化合物
ES2582575T3 (es) * 2008-07-09 2016-09-13 Nissan Chemical Industries, Ltd. Procedimiento para la producción de compuesto de amida del ácido benzoico sustituido con isoxazolina
WO2010059529A2 (en) 2008-11-19 2010-05-27 Merial Limited Compositions comprising an aryl pyrazole and/or a formamidine, methods and uses thereof
ES2442342T3 (es) 2008-12-18 2014-02-11 Novartis Ag Derivados de las isoxazolinas y su uso como pesticida
AR074790A1 (es) 2008-12-19 2011-02-09 Novartis Ag Derivados de isooxazol sustituidos, composiciones farmaceuticas y para el control de parasitos que los comprenden y su uso en metodos para controlar parasitos en y sobre animales de sangre caliente.
AR081843A1 (es) * 2010-06-09 2012-10-24 Syngenta Participations Ag Mezclas pesticidas incluyendo derivados isoxazolina
EP2593592B1 (en) 2010-07-15 2018-05-16 Luxembourg Institute of Science and Technology (LIST) Separation of master electrode and substrate in ecpr
JP6002148B2 (ja) 2010-12-27 2016-10-05 インターベット インターナショナル ベー. フェー. 経表面局所イソオキサゾリン製剤
CN103260620A (zh) 2010-12-27 2013-08-21 英特维特国际股份有限公司 包含三缩四乙二醇的外用局部异噁唑啉制剂
CA2826067A1 (en) * 2011-02-10 2012-08-16 Novartis Ag Isoxazoline derivatives for controlling invertebrate pests
JP6061934B2 (ja) * 2011-08-25 2017-01-18 シンジェンタ パーティシペーションズ アーゲー 殺虫化合物としてのイソオキサゾリン誘導体
WO2013026695A1 (en) * 2011-08-25 2013-02-28 Syngenta Participations Ag Isoxazoline derivatives as insecticidal compounds
HUE042360T2 (hu) 2011-09-12 2019-06-28 Merial Inc Izoxazolin hatóanyagot tartalmazó parazitaellenes készítmények, ezek elõállítása és alkalmazása
JP2014534182A (ja) * 2011-10-03 2014-12-18 シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト 殺虫化合物としてのイソオキサゾリン誘導体
DE102012200815B3 (de) 2012-01-20 2013-01-10 Dieter Kirsch Inhalationsunterstützungsvorrichtung und Verfahren zur Inhalationsunterstützung
CN108685894B (zh) * 2012-04-04 2022-04-26 英特维特国际股份有限公司 软咀嚼药用产品
ES2874054T3 (es) * 2013-12-20 2021-11-04 Intervet Int Bv Uso de derivados de isoxazolina para el tratamiento o la prevención de la infestación con artrópodos en aves de corral

Also Published As

Publication number Publication date
EP3878281A1 (en) 2021-09-15
EP3878281B1 (en) 2023-05-24
ES2950885T3 (es) 2023-10-16
BR112016014216A2 (enExample) 2017-08-08
US12128032B2 (en) 2024-10-29
EP3082806B1 (en) 2021-05-12
RU2688167C1 (ru) 2019-05-20
US10272071B2 (en) 2019-04-30
EP3082806A1 (en) 2016-10-26
MX376210B (es) 2025-03-07
US20160317502A1 (en) 2016-11-03
CN110839641A (zh) 2020-02-28
RU2019114185A (ru) 2019-06-27
CN105979944A (zh) 2016-09-28
JP2016540028A (ja) 2016-12-22
US20190192486A1 (en) 2019-06-27
PL3878281T3 (pl) 2023-07-31
US20220193040A1 (en) 2022-06-23
MX2020010997A (es) 2020-11-09
BR112016014216B1 (pt) 2022-08-30
US11304934B2 (en) 2022-04-19
PL3082806T3 (pl) 2021-09-13
HUE063842T2 (hu) 2024-02-28
WO2015091900A1 (en) 2015-06-25
US20200237727A1 (en) 2020-07-30
PT3082806T (pt) 2021-06-04
US10653675B2 (en) 2020-05-19
MX2016008119A (es) 2016-09-16
ES2874054T3 (es) 2021-11-04
RU2016129272A (ru) 2018-01-25
HUE055444T2 (hu) 2021-11-29

Similar Documents

Publication Publication Date Title
US12128032B2 (en) Use of isoxazoline derivatives for the treatment or prevention of arthropod infestations in poultry
JP6581586B2 (ja) イソオキサゾリン組成物および動物における寄生虫侵襲の予防または処置におけるその使用
JP6530753B2 (ja) イソオキサゾリン化合物の抗寄生生物薬使用
WO2021122521A1 (en) Composition for lice control in poultry
RU2796536C9 (ru) Применение изоксазолиновых соединений на домашней птице
RU2796536C2 (ru) Применение изоксазолиновых соединений на домашней птице
Sadariya et al. Therapeutics, Prevention, and Control of Parasitic Diseases
JP2004143050A (ja) 動物の外部寄生虫駆除用液剤
WO2026063805A1 (en) A pharmaceutical composition, medicated drinking water, their use and method of preparing medicated drinking water
RU2791637C2 (ru) Изоксазолиновые композиции и их применение в профилактике или лечении паразитарных инвазий животных
CN1233936A (zh) 防治温血动物被外寄生物再感染的方法
Henderson Multi-host tick management in autumn
Campbell EC99-1551-B Revised 2003 Nebraska Management Guide for Control of Arthrodpod Pests of Poultry and Pets
JP2002138002A (ja) 動物の外部寄生虫駆除用液剤
JP2002138007A (ja) 動物の外部寄生虫駆除用液剤
Albert Foot and health care of horses. 1103

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20171207

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20171207

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180911

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20181210

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20190305

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20190329

R150 Certificate of patent or registration of utility model

Ref document number: 6506763

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R153 Grant of patent term extension

Free format text: JAPANESE INTERMEDIATE CODE: R153

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250